3-[1-[3-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;4-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-(2,3-dihydro-1-benzofuran-6-yl)pyrazol-4-yl]benzoic acid;3-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid;4-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid
C108H88F6N12O13 — CID 158743162
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[1-[3-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;4-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-(2,3-dihydro-1-benzofuran-6-yl)pyrazol-4-yl]benzoic acid;3-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid;4-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid
3-[1-[3-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;4-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-(2,3-dihydro-1-benzofuran-6-yl)pyrazol-4-yl]benzoic acid;3-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid;4-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid (PubChem CID 158743162) has the molecular formula C108H88F6N12O13 and a molecular weight of 1875.95 g/mol. Its IUPAC name is 3-[1-[3-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;4-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-(2,3-dihydro-1-benzofuran-6-yl)pyrazol-4-yl]benzoic acid;3-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid;4-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid.
Molecular Properties
| Compound Name | 3-[1-[3-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;4-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-(2,3-dihydro-1-benzofuran-6-yl)pyrazol-4-yl]benzoic acid;3-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid;4-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid |
|---|---|
| PubChem CID | 158743162 |
| Molecular Formula | C108H88F6N12O13 |
| Molecular Weight | 1875.95 g/mol |
| Exact Mass | 1874.65 |
| IUPAC Name | 3-[1-[3-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;4-[1-[4-(1,1-difluoroethyl)phenyl]pyrazol-4-yl]benzoic acid;3-[1-(2,3-dihydro-1-benzofuran-6-yl)pyrazol-4-yl]benzoic acid;3-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid;4-[1-(3,4-dimethylphenyl)pyrazol-4-yl]benzoic acid |
| SMILES | CC(F)(F)c1ccc(-n2cc(-c3ccc(C(=O)O)cc3)cn2)cc1.CC(F)(F)c1ccc(-n2cc(-c3cccc(C(=O)O)c3)cn2)cc1.CC(F)(F)c1cccc(-n2cc(-c3cccc(C(=O)O)c3)cn2)c1.Cc1ccc(-n2cc(-c3ccc(C(=O)O)cc3)cn2)cc1C.Cc1ccc(-n2cc(-c3cccc(C(=O)O)c3)cn2)cc1C.O=C(O)c1cccc(-c2cnn(-c3ccc4c(c3)OCC4)c2)c1 |
| InChI | InChI=1S/3C18H14F2N2O2.C18H14N2O3.2C18H16N2O2/c1-18(19,20)15-6-8-16(9-7-15)22-11-14(10-21-22)12-2-4-13(5-3-12)17(23)24;1-18(19,20)15-6-3-7-16(9-15)22-11-14(10-21-22)12-4-2-5-13(8-12)17(23)24;1-18(19,20)15-5-7-16(8-6-15)22-11-14(10-21-22)12-3-2-4-13(9-12)17(23)24;21-18(22)14-3-1-2-13(8-14)15-10-19-20(11-15)16-5-4-12-6-7-23-17(12)9-16;1-12-3-8-17(9-13(12)2)20-11-16(10-19-20)14-4-6-15(7-5-14)18(21)22;1-12-6-7-17(8-13(12)2)20-11-16(10-19-20)14-4-3-5-15(9-14)18(21)22/h3*2-11H,1H3,(H,23,24);1-5,8-11H,6-7H2,(H,21,22);2*3-11H,1-2H3,(H,21,22) |
| InChIKey | IMOBLLOQCKSGKW-UHFFFAOYSA-N |
| XLogP | 23.93 |
| TPSA | 339.95 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 139 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1875.95 |
| LogP ≤ 5 | 23.93 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 19 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158743162 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.